# Study of Single Agent Lenalidomide in Older Adults With Newly Diagnosed Multiple Myeloma

> **NCT01054144** · PHASE2 · COMPLETED · sponsor: **H. Lee Moffitt Cancer Center and Research Institute** · enrollment: 27 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** Lenalidomide
- **DRUG:** Prednisone
- **DRUG:** Dexamethasone

## Key facts

- **NCT ID:** NCT01054144
- **Lead sponsor:** H. Lee Moffitt Cancer Center and Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01-14
- **Primary completion:** 2020-08
- **Final completion:** 2020-11-24
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2021-10-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01054144

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01054144, "Study of Single Agent Lenalidomide in Older Adults With Newly Diagnosed Multiple Myeloma". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT01054144. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*